Phase I Trial of Cisplatin and Etoposide Plus BKM120 in Advanced Solid Tumors, With an Emphasis on Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2019
Price : $35 *
At a glance
- Drugs Buparlisib (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 20 Jun 2016 Status changed from active, no longer recruiting to completed.
- 24 Mar 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTriasl.gov.
- 23 Jul 2014 New trial record